SCHEDULE: StemPoint Capital Discloses Stake in Surrozen Inc.

StemPoint Capital LP, along with affiliated entities and individuals, has reported a beneficial ownership of 4.5% in Surrozen, Inc. common stock.

Summary

• StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross have jointly filed a Schedule 13G, indicating their beneficial ownership of Surrozen, Inc. common stock.
• The reporting persons collectively own 525,639 shares of Surrozen, Inc. common stock.
• This ownership represents 4.5% of the class of securities.
• The reported shares include 195,981 directly owned shares and 329,658 shares issuable upon the exercise of warrants.
• The calculation of the percentage ownership is based on 11,486,707 shares outstanding as of March 19, 2026, plus exercisable warrants.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance data for Surrozen, Inc.

Positives

• StemPoint Capital has taken a significant stake, indicating confidence in Surrozen's potential.
• The ownership of 4.5% suggests a notable investment position.
• The inclusion of exercisable warrants indicates a potential for increased ownership and further investment.

Negatives

• The filing does not contain any negative financial or operational information about Surrozen, Inc. itself, as it is a disclosure of ownership.

Risks

• The beneficial ownership is subject to a 9.9% beneficial ownership limitation on certain warrants, which could affect the ability to exercise them fully.
• The filing is an amendment to a previous filing, suggesting ongoing changes in ownership or reporting.

Future Outlook

The filing does not contain forward-looking statements or guidance from Surrozen, Inc. It is a disclosure of beneficial ownership by StemPoint Capital.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes by institutional investors. The 4.5% ownership by StemPoint Capital in Surrozen, Inc. suggests a significant but likely non-controlling interest, common in the biotechnology sector where strategic investments are frequent.

Stakeholder Impact

• Shareholders of Surrozen, Inc. are informed of a significant institutional investor's stake, which could influence market perception.
• Potential investors may view this filing as an indicator of institutional confidence in Surrozen, Inc.

Next Steps

• StemPoint Capital will continue to monitor its investment in Surrozen, Inc.
• Future amendments to the Schedule 13G may be filed if ownership levels change significantly.

Key Dates

Keywords

Surrozen Inc., StemPoint Capital LP, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Investment, Shareholder